Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients
1 other identifier
interventional
102
1 country
1
Brief Summary
The quality of colon cleansing has a major impact on efficiency and cost of colonoscopy. A hand-out was made to instruct and motivate patients to adequately clean the bowel before colonoscopy. The aim of the study is to compare adequacy of bowel cleansing in hospitalized patients receiving the hand-out or not on the day before colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 8, 2005
CompletedFirst Posted
Study publicly available on registry
September 12, 2005
CompletedSeptember 13, 2006
September 1, 2006
September 8, 2005
September 11, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of overall colon cleansing
Secondary Outcomes (6)
Quality of cleansing in the ascending colon,
Frequency of inadequate preparation and of failed procedure,
Time to intubate the caecum,
Cost-effectiveness of the self-administered leaflet,
Patient compliance with the self-administered leaflet,
- +1 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- Total colonoscopy scheduled during hospital stay in the Hôpital Universitaire de Genève (excluding dependencies);
- Ability to read and write at least one of the following languages : French, English, Spanish, Portuguese.
You may not qualify if:
- Colonoscopy scheduled under general anesthesia;
- Occupation inside the healthcare professions;
- Previous colonoscopy, colostomy or colectomy;
- Megacolon or idiopathic pseudo-obstruction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gastroenterology and Hepatology Division, University Hospital of Geneva
Geneva, 1205, Switzerland
Study Officials
- STUDY CHAIR
Jean-Marc Dumonceau, MD,PhD
University Hospital, Geneva
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- DIAGNOSTIC
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 8, 2005
First Posted
September 12, 2005
Study Start
September 1, 2005
Last Updated
September 13, 2006
Record last verified: 2006-09